Chengping Li
Impact in
-
- CRISPR and Genetic Engineering
- RNA and protein synthesis mechanisms
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Cell death mechanisms and regulation
- Natural product bioactivities and synthesis
-
- Sesquiterpenes and Asteraceae Studies
Papers in
-
- Natural product bioactivities and synthesis 5
- RNA Research and Splicing 4
- RNA modifications and cancer 4
- Cell death mechanisms and regulation 3
- RNA and protein synthesis mechanisms 3
- Ubiquitin and proteasome pathways 2
- Co-authors
- Myeong‐Sok Lee (8 shared papers)Samil Jung (8 shared papers)Wei‐Guang Shan (5 shared papers)Zha‐Jun Zhan (5 shared papers)Jong‐Seok Lim (6 shared papers)Young Yang (6 shared papers)Yan Guo (4 shared papers)Keun‐il Kim (5 shared papers)
- Journals
- International Journal of Oncology (4 papers)Oncotarget (2 papers)Bioscience Biotechnology and Biochemistry (2 papers)Journal of Agricultural and Food Chemistry (2 papers)Cell Research (1 paper)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Chengping Li
38 papers receiving 498 citations
Peers
Comparison fields: 5 of 70
- Molecular Biology 340
- Cancer Research 68
- Virology 21
- Business and International Management 9
- Pharmacology 19
Countries citing papers authored by Chengping Li
This map shows the geographic impact of Chengping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengping Li more than expected).
Fields of papers citing papers by Chengping Li
This network shows the impact of papers produced by Chengping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengping Li. The network helps show where Chengping Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chengping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 51 | |
| 2 | 2023 | 45 | |
| 3 | 2022 | 45 | |
| 4 | 2021 | 30 | |
| 5 | 2024 | 27 | |
| 6 | 2021 | 25 | |
| 7 | 2018 | 24 | |
| 8 | 2007 | 22 | |
| 9 | 2015 | 22 | |
| 10 | 2009 | 16 | |
| 11 | 2011 | 16 | |
| 12 | 2015 | 16 | |
| 13 | 2012 | 14 | |
| 14 | 2009 | 13 | |
| 15 | 2014 | 12 | |
| 16 | 2020 | 11 | |
| 17 | 2021 | 10 | |
| 18 | 2015 | 10 | |
| 19 | 2023 | 9 | |
| 20 | 2019 | 8 |
About Chengping Li
Chengping Li is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Oncology and Organic Chemistry, having authored 41 papers that have together received 509 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (5 papers), RNA Research and Splicing (4 papers), Autophagy in Disease and Therapy (4 papers), RNA modifications and cancer (4 papers), Cell death mechanisms and regulation (3 papers), Lipid metabolism and biosynthesis (3 papers), RNA and protein synthesis mechanisms (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Molecular Biology (340 citations), Cancer Research (68 citations), Virology (21 citations), Business and International Management (9 citations) and Pharmacology (19 citations). Chengping Li has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Myeong‐Sok Lee, Samil Jung, Wei‐Guang Shan, Zha‐Jun Zhan, Jong‐Seok Lim, Young Yang, Yan Guo, Keun‐il Kim, Jiyeon Ohk and Guoli Zhou. Their work appears in journals such as International Journal of Oncology, Oncotarget, Bioscience Biotechnology and Biochemistry, Journal of Agricultural and Food Chemistry and Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.